Vol.
170,
No.
July
31, 1990
2, 1990
BIOCHEMICAL
RESEARCH
COMMUNICATIONS Pages
VIA
MASTOPARAN, PERTUSSIS
A WASP VENOM, TOXIN-SENSITIVE Yuki
Yukio Ozaki*, Masaaki Higashihara**, *Department **First
of
of
Yutaka Kariya***,
Laboratory Yamanashi,
Medicine,
Saga
Yatomi**, and Shoji
Medicine, Japan
Internal Medicine, of Tokyo, Tokyo
Internal
779-785
ACTIVATES PLATELETS GTP-BINDING PROTEINS
Matsumoto*, Toshitsugu
Clinical and Medical College,
Department of University
***Department Received
BIOPHYSICAL
AND
Yamanashi
Faculty ,Japan
Medical
Kume*
of
Medicine,
College,
Saga
,Japan
May 29, 1990
SUMMARY: Mastoparan induced limited release of serotonin from intact human platelets, while neither intracellular calcium ion elevation nor arachidonic acid mobilization was observed. Cytolysis induced by mastoparan was negligible in the concentration range that induced serotonin release. In digitoninpermeabilized cells ,++mastoparan induced Ca++-independent release arachidonic acid release. of serotonin and Ca -dependent Both serotonin release and arachidonic acid release were reduced by pertussis toxin, suggesting that platelet activation induced by mastoparan is mediated by GTP-binding proteins. 01990 kademic Press, Inc.
from
Mastoparan
is
wasp
(1).
venom
nulation,
it
It
activities. helical its
been is
binding
to
hydrolysis aspect
has
or
(2).
(5) neutrophils,
to
have
This
and
for
of
a wide
of
of
mechanism
functional
islets,
biologic an alphato
phosphatidylRecently, of
a
mastoparan-
GTP-binding have
degra-
contributes
A2 (4).
workers
pancreatic
cell
assumes
probably
mastoparan-induced and
mast
stimulation
the
isolated
range
which
involves
modifies
inhibits
report
phospholipase
Several
which
originally
property
(3).
which
toxin
peptide
proposed
G proteins. toxin
first
an amphiphilic
been
proteins
proteins
found
by purified
activation,
pertussis
the
calmodulin
induced
cells,
Since
configuration
choline new
has
a tetradecapeptide
regulatory
demonstrated
that
properties
of
activation
of
especially
that
G
mast of
0006-291X/90 $1.50 779
Copyright 0 1990 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol.
170,
No.
2, 1990
intracellular
Cat+
Higashijima
fi
incorporated
igated
the
in of
our
paper
mastoparan
cell
types, has
release dealing
from
have its
not
platelets
mastoparan-induced we are
platelet
attempted
induced
by
activation
stimulates
effect fully
was
reported
G proteins
that
mastoparan
receptors
been
been
cell to
Furthermore,
agonist-liganded
of
COMMUNICATIONS
(6-8).
suggesting
by mimicking
of
RESEARCH
mastoparan
bilayers,
knowledge,
communication, activation
that
lipid
BIOPHYSICAL
mobilization
found
effects
a number
serotonin
induced
&
G proteins
While
AND
([Ca++]i)
into
activates
best
BIOCHEMICAL
(9).
extensively
invest-
on platelets,
to
evaluated; in
activation
the
the
limited very
first In
(1).
this
clarify
what
aspects
of
mastoparan,
and
whether
mastoparan-
via
G proteins.
is
MATERIALS
mediated
platelet
ANJ) METHODS
Mastoparan was obtained from Peptide Institute (Osaka, Japan). Pertussis toxin was purchased from List Biological Laboratories (CA, USA). Platelet-rich plasma was obtained from venous blood of healthy Platelets were isolated from plasma by centrifugation, donors. washed with a Hepes-Tyrode’s buffer containing 129 mM NaCl, 2.8 mM KCl, 0.8 mM KH2P04, 8.9 mM NaHC03, 0.8 mM MgCl 10 mM Hepes an resuspended in t i e same buffer and 5.5 mM glucose, (PH 7.2), at a cell concentration of 2 x 10I3 /ml, unless otherwise stated. Release of serotonin and arachidonic acid mobilization m asured with [3H]arachidonic acid-loaded cells and w”pt’z [ 8 Hlserotonin-loaded cells, respectively. Platelets were activated with various concentrations of mastoparan for 10 min at 37” c, and released label was expressed as percentage tothetotal radiolabel incorporated into platelets. Platelet [Ca++]i was measured with fura 2, a Ca++ -sensitive fluorescent dye, incorporated into cells. Fura 2 fluorescence was detected with dual-wave fluorescence spectrophotometry using a Hitachi F-2000 fluorescence spectrophotometer. Cell permeabilization was performed with digitonin. Briefly, platelets were suspended in a buffer containing 130 M KCl, 11.9 mM NaHC03, 0.42 mM NaH P04, 2 mM MgCl2, 5.6 mM glucose, and 10 mM Hepes (pH 7.4). 2 fter the addition of 1 mM EGTA, 1 ILM prostaglandin 12, and 20 Dg/ml digitonin, the cell suspension was incubated another 10 min at room temperature. Platelets were esuspended in the same buffer at a cell then washed once, and concentration of 2 x 10 B/ml. treatment: toxin was Pertussis toxin Pertussis preactivated with 20 mM dithiothreitol at 37” C for 30 min. Pertussis toxin (2.5 ,ug/ml) , 2 mM ATP and 0.2 mM NAD were added to the cell suspension of permeabilized platelets, and the mixture were incubated for 20 min at room temperature. Controls consisted of a permeabilized cell suspension with ATP and NAD but without pertussis toxin, and a non-permeabilized cell suspension with pertussis toxin, ATP and NAD. 780
Vol.
170,
No.
BIOCHEMICAL
2, 1990
AND
RESULTS Mastoparan release, Since
which a
far
abilized
was
not
which
membranes
bovine
adrenal
mine
release
upon
cell
with
may not
been
activation
concentration cannot
below
range
contrast
mastoparan
with
induced
cell the
neither
of
COMMUNICATIONS
described provide
to
induced
extracellular
serotonin
serotonin
Cat+
was
released
elsewhere an easy
(Fig. from
in
entry
for
in
upon
intact
intracellular
amount
of
suggesting
that
paper,
mastoparan. catechola-
cell
lysis,
platelets LDH
released
1). perme-
this
mastoparan-induced
be dependent
of the
to
by
However,
tested,
be attributed In
shown
release far
manner
cells,
(10).
mastoparan, or
is
chromaffin
has
negligible
affected
amount
RESEARCH
AND DISCUSSION
a dose-dependent
greater
cells,
platelet In
in
BIOPHYSICAL
not treated
was
almost
serotonin
in
serotonin
the
release
lysis. positive
effect
arachidonic
on acid
serotonin release
release, nor
[Ca++]i
30 % & ; u” m 2 2 2
01
0 Mastoparan
Figjre
1.
( u g/ml)
Serotonin
and LDH release
5 Mastoparan
10
20 (II
g/ml)
induced by mastoparan.
A [ Hlserotonin-loaded platelet suspension was incubated indicated concentration of mastoparan for 10 nin at platelet suspension was then rapidly centrifuged, resultant supernatant was assayed for released serotonin (Open circles, serotonin; closed circles, LDH) The presented as the means *SD of 5 experiments.
with C. and and data
37”
the The the LDH. are
Figure & Effect of Ca++ on serotonin release from permeabilized pjatelets induced by mastoparan. [ Hlserotonin-loaded platelets were permeabilized with digitonin and resuspended in a buffer containing either 10 DM Ca*+ or 1 mM EGTA. Mastoparan at the indicated concentration was added to the platelet suspension, and the mixture was incubated for 10 min at After rapid centrifugation, 37” c. the supernatant was assay for the content of released serotonin. (Open circles, Ca++ 10 ,uM; closed circles, EGTA 1 mM) The data are presented as the means +SD of 3 experiments.
781
40
Vol.
170,
No.
2, 1990
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
1 2.5
5 Mastoparan
10 ( p g/ml)
COMMUNICATIONS
I
x 20
40
Figure 3. Arachidonic acid mobilization from permeabilized induced by mastoparan. pJatelets [ Hlarachidonic acid-loaded platelets were permeabilized with digitonin and resuspended in a buffer containing either 100 UM Ca++ or 1 mM EGTA. Mastoparan at the indication concentration was added to the cell suspension, and the mixture was incubated for 10 min at 37” C. After incubation, the cell suspension was rapidly centrifuged, and the supernatant was assayed for the released arachidonic acid. (open circles, 100 PM Ca** ; closed circles, 1 mM EGTA) The data are presented as the means +SD of 3 experiments.
elevation
in
intact
[Ca+‘]i
elevation
lipase
C activation,
against
mastoparan
tion
pathway
dependent tion
(7,
A2
activation 11).
of
In stimulator U/ml
Ca++,
G proteins
It signal
which
AZ.
is
In
transducindependent
lack are
with
show G protein-
C upon mastoparan
that
be
may
contrast
neutrophils
platelets
digitonin-permeabilized of
serotonin
for
cells,
release,
As observed
release
suggesting
mastoparan
and
release,
stimula-
certain
linked
types
to
of
phospholipase
to be elucidated.
thrombin.
serotonin
release,
phospholipase
Whether
mastoparan-sensitive C awaits
cells
acid
a certain
of
phospho-
respectively.
phospholipase
mast
against
of arachidonic
serotonin
C or
intact
absence
stimulates
for
The absence
shown). evidence
activation,
selectively
phospholipase
not
indirect
and the
required
platelets,
(data
provides
phospholipase
that
of
platelets
comparable
with
intact
was unaffected that
serotonin
the
signal release
mastoparan
by
to
782
independent
effect
the
presence
transduction is
the
cells,
the
was a potent of
0.5
magnitude
of
or
absence
of
pathway
employed
by
of
(Fig.
Ca**
2).
Vol.
170,
No.
2, 1990
BIOCHEMICAL
Arachidonic
acid
platelets.
As
M
could
not in
the
(Fig.
In
release
is
requires
the
contrast
with
from
derived
from
presence in
on the
of
part
phospholipase
that
ILL
Thr. (+)
mastoparan
04
(-)
Thr.
(-)
(-)
Mast. (-)
C-1 (+I
0
Mast. (+)
5
Agonist IAP
U/ml
Ca++ acid
of
was
acid
cells
does not
elevate
(-) (6)
which
arachidonic
intact
1 Thr. (-)
Mast. (-)
acid be
may
[Ca”]i
C-1 (+)
Thr. (+)
Figure 4. Effect of pertussis toxin on serotonin release induced by massoparan or thrombin. [ Hlserotonin-loaded platelets were permeabilized with digitonin and further treated either with 2.5 Dg/ml pertussis of saline for 20 min. Platelets toxin or an equivalent volume were then activated either with 0.4 U/ml thrombin or with 20 fig/ml the reaction w s terminated and the mastoparan. After 10 min. supernatant was assayed for the released [ 8 Hlserotonin. The data (open columns, no are presented as the mean of 2 experiments. dotted columns, thrombin 0.4 U/ml: hatched columns, stimul~ator; mastoparan 20 fig/ml). Figure 5. Effect of pertussis toxin on arachidonic acid mobilization induced by mastoparan or thrombin. j3H]arachidonic acid-loaded platelets were permeabilized with digitonin and further treated either with 2.5 ug/ml pertussis Platelets toxin or an equivalent volume of saline for 20 min. were then activated either with 0.4 U/ml thrombin or with 20 .ag/ml mastoparan. After 10 rain, the reaction was terminated and the the released [3H]arachidonic acid. supernatant was assayed for The data are presented as the mean of 2 experiments thrombin 0.4 :yiE? columns, no stimulator; dotted columns, hatched columns, mastoparan 20 fig/ml). 783
a
release
arachidonic
of
n
Agonist IAP
0.4
A2 activity,
The absence
mastoparan-activated
cells.
by
arachidonic
lo-*
arachidonic
release,
a larger
Ca++.
ground
permeabilized
induced
serotonin
the
up to
massive
that
mastoparan-induced
permeabilized
Ca++alone
induced
to
human platelets,
mobiliza.tion explained
Ca++
COMMUNICATIONS
with
(12-13), acid
of
RESEARCH
evaluated
reported
presence
for
3).
also
comparable
In
prerequisite
BIOPHYSICAL
arachidonic
mobilization,
thrombin.
was
previously
liberate
Mastoparan acid
release
AND
Mast (+)
Vol.
170,
in
No.
2, 1990
intact
platelets:
activation signal
aroused
have concept
been
with
that
the
to
control
suggesting
that
the
G proteins
of serotonin
findings
of
suppressed
Kajiyama
arachidonic
acid
G proteins.
arachidonic
arachidonic
was
acid
suggesting arachidonic
(data
toxin
the
(Fig.
4).
successfully
the
with
permeabiliz-
induced with
with
cytoplasm
With
ROW
by
20
pertussis
mastoparan
fig/ml
toxin,
was
mediated
from
permeab-
4).
Thrombin-induced cells
into
of
from
stimulation
were
suppressed effect
cells
toxin
the
be
magn-
intact
thrombin
release
stimulatory
the
preincubated
G proteins.
remarkably
(Fig.
the
platelets toxin
to
different
without
that
need
from
upon
incubated
cell toxin
While
without
serotonin
of
on
cells
platelets
treated, also
induced
significantly
incubated
ADP-ribosylation
was
Ca++,
not
pertussis
effect
toxin.
release
less
This
pertussis
cytoplasm: the
types
proteins.
platelets,
with
was
cell
inhibitory
serotonin
cells
let
mastoparan
with
treatment
cells
to
thus
ilized
A2
activation
G proteins
the
substantiate
permeabilized
via
an
on several
the
human
into
released
findings
cells
and
GTP-binding
by
with
toxin
permeabilized
subsequent
COMMUNICATIONS
phospholipase
Ca++
ADP-ribosylates
up
the
toxin
These
of
via
digitonin-permeabilized
pertussis
of
mastoparan
mediated
thrombin-induced
shown),
presence
substantiated
prior
incubated
ed
be
taken
permeabilized
with
RESEARCH
picture
of
However,
readily
of
the
which
(5-9).
not
than
to
toxin
function
full
effects
shown
pertussis
BIOPHYSICAL
by mastoparan.
has
itude
both
stimulator-y
been
AND
the
may need
The
is
BIOCHEMICAL
et -A
al
acid by
pertussis
(13)
and
mobilization Similarly, release that acid
induced pertussis
induced
mobilization toxin, Nakashima by toxin
&
are
mobilization 784
in
5).
the in
the
(14) was
effectively
involved (Fig.
al.
thrombin
by mastoparan
G proteins
confirming
that
coupled blocked
presence mastoparan-
of
Vol.
170,
No.
2, 1990
Our and
findings
serotonin is
addition,
activate
pase
it
(most C.
particular thesis, the
is
direct
subsets
of
role
of
G proteins
in
activated
without
is
of
for
tools
to
binding
prove for
serotonin phospholi-
mastoparan
essential
by
selectively
activating
useful
platelet
may
pathways
demonstration
provide
mobilization
G proteins.
mastoparan
transduction
will
acid
platelets
that
G proteins
COMMUNICATIONS
toxin-sensitive
G proteins)
While
mastoparan
arachidonic
pertussis
suggested
probably
RESEARCH
permeabilized
by
signal
BIOPHYSICAL
that
from
mediated
certain
release
AND
demonstrate release
mastoparan In
BIOCHEMICAL
this
to hypo-
investigating
function.
REFERENCES 1. and
Hirai,Y., Kitada,
Yasuhara,T., Yoshida,H., Nakajima,T., Fujino,M., (1979) Chem. Pharm Bull. (Tokyo) 27, 1942-1944 Wakamatsu K Higashijima,T., Fujino,M., Nakajima,T., and iiyazawa,T. (i983) FEBS Lett. 162, 123-126 3. Cachia,P.J., Van Eyk,J.E., Ingraham,R.H., McCubbin,W.D., Kay,C.M., and Hodges,R.S. (1986) Biochemistry 25, 3553-3562 4. Angiolas,A., and Pisan0,J.J. (1983) J. Biol. Chem.258, 1369713702 5. Ohta, H., Okajima, F., and Ui, M. (1985) J. Biol. Chem. 260, 15771-15780 6. Higashijima, T., Uzu, S., Nakajima, T., and Miyazawa, T. (1987) In Peptide Chemistry 1986. T. Miyazawa, ed. Protein Research Foundation, Osaka, Japan, pp.75-78 7. Perianin, A., and Snyderman, R. (1989) J. Immunol. 143, 1669C.
1673
8. Yokokawa, N., Komatsu, M., Takeda, T., Aizawa, T., and Yamada, T. (1989) Biochem. Biophys. Res. Commun. 158, 712-716 9. Higashijima, T., Uzu, S., Nakajima, T., and Ross, E.M. (1988) J. Biol. Chem. 263, 6491-6494 10. Wilson, S.P. (1989) FEBS Lett. 247, 239-241 11. Okano, Y., Takagi, H., Tohmatsu, T., Nakashima, S., Kuroda, Y Saito, K., and Nozawa, Y. (1985) FEBS Lett. 188, 363-366 12: Nakashima, S., Suginuma, A., Matsui, A., Hattori, H., Sato, M Takenaka, A., and Nozawa, Y. (1989) Biochem. J. 259, 139-144 13: Kajiyama, Y., Murayama, T., and Nomura, Y. (1989) Arch. Biochem. Biophys. 274, 200-208 14. Nakashima, S., Hattori, H., Shirato, L., Takenaka, S., and Nozawa, Y. (1987) Biochem. Biophys. Res. Commun. 148, 971-978
785